Eton Pharmaceuticals (ETON)
(Delayed Data from NSDQ)
$18.34 USD
-0.12 (-0.65%)
Updated Sep 19, 2025 03:59 PM ET
After-Market: $18.29 -0.05 (-0.27%) 7:58 PM ET
5-Strong Sell of 5 5
F Value A Growth D Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Eton Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ETON 18.34 -0.12(-0.65%)
Will ETON be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ETON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ETON
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
ETON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
Other News for ETON
MACD Bullish Signal Line Cross appears for ETON after 0.65% move
Is ETON coiling for a breakout? Bollinger Band Squeeze shows up after gaining 4.41%
Bollinger Band Squeeze appears for ETON after 0.68% move
New Uptrend appears for ETON after 1.24% move
ETON Hosts Virtual Meeting on September 25